IMMUNO-BIOLOGICAL LABORATORIES CO financial statements, including revenue, expenses, profit, and loss

The total revenue of 4570 for the last quarter is 182.89 M JPY, and it's 2.89% lower compared to the previous quarter. The net income of Q3 23 is -6.27 M JPY.